Le Lézard
Classified in: Health, Science and technology
Subject: PDT

ProductLife Group and Juuka Advisory team up to launch ProductLife Consulting


PARIS, Sept. 20, 2021 /PRNewswire-PRWeb/ -- Regulatory compliance outsourcing services specialist, ProductLife Group ("PLG") and strategy and operations consulting company, Juuka Advisory ("Juuka"), have teamed up to form a new consulting venture, ProductLife Consulting.

Juuka Advisory, a strategy consulting specialist for the Life Sciences & Cosmetics industries handles more than 50 consulting projects per year and is facing increasing demands from customers, of which 25% are located in France, 35% in Europe (outside France) and 40% outside Europe.

ProductLife Group is a leader in overseeing the regulatory product lifecycle of drugs and medical devices, and supports 400 clients in more than 140 countries: its profile matches perfectly with Juuka's needs for expansion. PLG was already fielding requests from key customers to help them with strategic decisions prior to outsourcing projects.

Juuka and PLG are now joining forces to pool their consulting expertise and operational excellence in a new business unit named ProductLife Consulting.

ProductLife Consulting will be headed by Juuka CEO Jean-Luc Taborin. With an operational background in major industrial groups as Business Unit director, and an extensive consultancy experience at Deloitte and Roland Berger, Jean-Luc perfectly understands the Life Sciences industries and their challenges.

Recently, digital and business model disruption has surfaced as the driving factor behind growth, especially in the more mature Life Sciences markets. ProductLife Consulting will cover these issues, as well as :

In addition, ProductLife Consulting will provide specific support in Market Access (pricing and reimbursement from strategy to negotiations). A key trend in life sciences and healthcare is the requirement for pharma industries to sell their drugs on the largest scale possible, a situation in which they are often confronted with substantial diversity in national regulations.

The new entity will retain Juuka's fundamentals: consulting vision, oversight of the operational feasibility of the proposed solutions, agility, and - of course ? the expertise of Jean-Luc.

"I'm proud to join PLG, a leader in regulatory compliance outsourcing services," said Jean-Luc Taborin, CEO of Juuka Advisory. "With their knowledge of drug development, we'll be able to tackle any perspective of the development of pharma, biotech, medtech or cosmetics companies end-to-end.

Xavier Duburcq, CEO of ProductLife Group, said : "This is a key milestone in PLG's roadmap to strengthen its consulting offering with senior principals such as Jean-Luc and his team. PLG's service offering and global footprint can now be proposed as a follow-up to any strategic recommendation that ProductLife Consulting makes to groups that want to accelerate and perform in their markets."

About ProductLife Group (PLG)

ProductLife Group's mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions. For almost 30 years, PLG has supported clients through the entire product lifecycle, combining local expertise with a global reach spanning more than 110 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, vigilance and medical information, covering both established products and innovative therapeutics & diagnostics. With a goal of continuously improving the value delivered to customers, PLG is committed to long-term partnership, innovation, flexibility and cost efficiency.

For more information, visit productlifegroup.com

Contact

Fabrice Galzin
ProductLife Group Head of Marketing
fgalzin@productlife-group.com
Mobile : +33 (0) 672 349 606

Media Contact

Carina Birt, Sarum PR, +44 7970006624, carina@sarumpr.com

Gillian Reading, Sarum PR, 7799153550, gillian@sarumpr.com

 

SOURCE ProductLife Group


These press releases may also interest you

at 07:15
Titan Pharmaceuticals, Inc. ("Titan" or the "Company") today announced that it has received funding from the Bill & Melinda Gates Foundation to support the demonstration of its ability to deliver a human immunodeficiency virus ("HIV") preventative...

at 07:05
Taysha Gene Therapies, Inc. , a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large...

at 07:05
Kiromic BioPharma, Inc. ("Kiromic" or the "Company"), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) platform to discover and develop cell and gene therapies with a therapeutic...

at 07:05
Concert Pharmaceuticals, Inc. today announced that it has completed patient enrollment in THRIVE-AA1, the first Phase 3 clinical trial to evaluate the efficacy and safety of CTP?543, an oral Janus kinase (JAK) inhibitor, in adult patients with...

at 07:05
OncoNano Medicine, Inc. today announced that the Cancer Prevention and Research Institute of Texas (CPRIT) will convert $18.4 million in grant award funding into an equity investment in OncoNano. Proceeds of the financing will be used to support...

at 07:05
Castle Biosciences, Inc. , a company applying innovative diagnostics to inform disease management decisions and improve patient outcomes, today announced that it will release its financial results for the third quarter and nine months ended Sept. 30,...



News published on 20 september 2021 at 07:00 and distributed by: